Vmbook Online ordering

Icons

**Company Information**

**Name:** Icon PLC

**Symbol:** ICN

**Exchange:** New York Stock Exchange (NYSE)

**Briefcase Business**

Icon is a global provider of outsourced development services for the pharmaceutical, biotechnology, and medical device industries. Its briefcase business includes:

* Clinical research services

* Regulatory affairs

* Medical writing

* Data management

**Earnings and Growth**

**Recent Earnings:**

* Q4 2022: Revenue of $397.2 million, up 13.5% year-over-year

* Net income of $53.9 million, up 20.1% year-over-year

**Growth Metrics:**

* Revenue growth over the past 5 years: 10.6% CAGR

* Net income growth over the past 5 years: 12.3% CAGR

* Backlog of orders as of Q4 2022: $1.8 billion

**Financial Highlights**

* Market capitalization: $3.6 billion

* Price-to-earnings (P/E) ratio: 25.4

* Price-to-sales (P/S) ratio: 2.3

* Dividend yield: 0.6%

**Key Strengths**

* Strong track record of growth and profitability

* Diversified customer base

* Global presence

* Focus on high-growth areas of the healthcare industry

**Key Risks**

* Competition from other CROs

* Regulatory changes in the healthcare industry

* Dependence on a few large clients

**Analyst Outlook**

Analysts are generally bullish on Icon's prospects. They believe that the company's strong growth momentum, diversified business, and focus on high-growth areas will continue to drive shareholder value.